COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, ...

A new study looked at the long-term prognosis of French people who were hospitalised between 2020 and 2022 for heart ...

Purpose: The treatment options for viral myocarditis caused by coxsackievirus B are summarized. Summary: Myocarditis is a common cause of dilated cardiomyopathy. The most common causes of ...

These are all indicators of an inflammation of the heart muscle, known as Myocarditis. An astonishing 82% wouldn't seek ...

Even though most of the time, it is nothing to worry about, however, many experts feel it can be a sign of myocarditis - a ...

New research has found that patients who developed inflammation of the heart, or myocarditis, after receiving an mRNA vaccine for COVID-19 had fewer complications in the 18 months after ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window People with postvaccine myocarditis did not share the typical mid-term complications associated with conventional ...

The study investigates COVID-19 vaccine-related myocarditis in adolescents, revealing clinical characteristics and risks of ...

The new COVID-19 vaccines based on mRNA technology are no exception. But one risk associated with them—myocarditis, especially for young men—has raised concerns among the public. A new study ...

Even with a low rates of cardiovascular adverse events in patients treated with immune checkpoint inhibitors, cancer care ...

Introduction Wearable cardioverter-defibrillators (WCD) have emerged as a valuable tool in the management of patients at risk ...

Mean treatment duration (months) 8.1 ± 0.7 8.7 ± 1.4 8.2 ± 1.6 8.6 ± 1.2 a All groups were treated with conventional heart failure therapy (digoxin, diuretics, and vasodilators) throughout the ...